Occam Global is the executive search firm and leadership advisory partner for entrepreneurs, investors, and corporations pursuing exceptional goals in frontier technologies, including life sciences, defense, robotics, and venture capital, worldwide.
Since 2012, Occam has partnered with leading founders, CEOs, and investors across life sciences and deep tech to deliver high-performing C-suite and board leadership. From stealth startups to public markets, we run retained executive search, advise on organizational strategy, and invest alongside visionary teams building category-defining companies.
Our edge: an unmatched ability to attract exceptional business and scientific leaders, seamless access to rare talent, and a relentless commitment to results — guided by high ethics and enlightened aggression.
Whether you’re launching, leading, or investing, Occam fuels growth through the power of talent. Visit occam-global.com to learn more.
Occam was founded in 2012 on a simple yet uncommon belief: executive search could be more creative, thoughtful, and principled than the industry norm.
After a 25-year career shaping leadership at Fidelity Investments, William ”Bill” Holodnak partnered with his son, John, to build a firm defined by focus, judgment, and ethics.
From the beginning, we chose to partner closely with founders and entrepreneurial leaders as they navigate moments that define their companies. We understood that early-stage and high-growth businesses require more than resume shuffling — they require judgment calls made under incomplete information, the kind no algorithm can make for you. Today, Occam is a global executive search firm trusted by founders, boards, and investors in high-stakes leadership moments.
That judgment is built from pattern recognition — hundreds of these decisions, across every stage from founding team to post-IPO board — brought to bear on the search in front of us. It’s why investors bring us in before the problem is even fully defined, and why the leaders we place deliver proven track records, real impact, and long-term value.
We built our firm on the pillars of objectivity, undiluted ethics, and enlightened aggression.
With a process that’s rooted in relationships, data, and intellect, we’ve provided professional judgments that have made a lasting impact on our partners.
Our judgements are simultaneously inspired by instinct and pragmatism, resulting in balanced outcomes designed to endure.
In May 2025, Occam Global, a leading biotech executive recruiting firm, placed Angus Sinclair, PhD, as Chief Scientific Officer at London-based LabGenius Therapeutics. As CSO, Sinclair will leverage his extensive experience in drug discovery to lead LabGenius’ scientific strategy, driving innovation in both pipeline and platforms. Angus joins LabGenius from IGM Biosciences, where he was
Metsera (Nasdaq: MTSR) is a clinical-stage biotech focused on developing the next generation of medicines for obesity and metabolic disease. In May 2025, Occam placed Matt Lang as its Chief Legal Officer & Corporate Secretary. Prior to Metsera, Matt had a multidimensional business career culminating in his service as Chief Business & Legal Officer of
In May 2025, Occam Global recruited Jay Barth, MD as CMO of eGenesis. Dr. Barth is a serial biotech CMO with rich experience shepherding the clinical progress of novel modalities across diverse disease states. He joins eGenesis from Ascidian Therapeutics, where he led the company’s RNA Exon Editing technology into the clinic. His prior roles include that of CMO for orphan
In early 2025, Occam Global placed McDavid Stilwell as CFO of CPTx, a company pioneering the development of in vivo genetic medicines built on single-stranded DNA. CPTx’s lead development programs include a next-generation in vivo CAR-T therapy and a novel, programmable, non-viral self-delivering gene nanocarrier. Stilwell is an industry veteran with more than 25 years
Case Studies
Read about how Occam Global is helping innovative organizations tackle their biggest executive recruitment challenges
Blog & Insights
Discover new tips, industry news and guides by Occam Global
-Latest Interview: Whit Bernard, CEO of Metsera